Gary Lyons
Board Member
Travere Therapeutics, Inc. (TVTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gary Lyons
Gary Lyons is recorded as Board Member at Travere Therapeutics, Inc. (TVTX). Travere Therapeutics, Inc. reported in an 8-K filed May 16, 2025 that Gary Lyons was appointed Director, effective May 15, 2025. Travere Therapeutics, Inc. reported in an 8-K filed May 13, 2024 that Gary Lyons was appointed Director, effective May 8, 2024. Travere Therapeutics, Inc. reported in an 8-K filed May 22, 2023 that Gary Lyons was appointed Director, effective May 17, 2023.
“The Company's stockholders elected the ten persons listed below to serve until the Company's 2026 Annual Meeting of Stockholders.”
“The Company’s stockholders elected the ten persons listed below to serve until the Company’s 2025 Annual Meeting of Stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2014-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Travere Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Bradley Campbell CEO, Board Member
- Bradley L. Campbell CEO, Board Member
- Christopher Cline CFO
- Elizabeth E. Reed General Counsel
- Sandra Calvin Chief Accounting Officer
- Jeffrey Meckler Board Member
- John A. Orwin Board Member
- Ron Squarer Board Member
- Roy Baynes Board Member
- Roy D. Baynes Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.